Esperion Therapeutics, Inc. (ESPR)
NASDAQ·Healthcare·Biotechnology
$3.16
+0.16%
Mkt Cap $650.75M
Analyst Ratings
Buy
1
Hold
2
Sell
0
Price Target (9 analysts)
$3.19
Range $3.16 – $3.28
Implied Upside
+1.1%
Consensus $3.19 vs current $3.16
NASDAQ·Healthcare·Biotechnology
$3.16
+0.16%
Mkt Cap $650.75M
Buy
1
Hold
2
Sell
0
Price Target (9 analysts)
$3.19
Range $3.16 – $3.28
+1.1%
Consensus $3.19 vs current $3.16